Diego Arroyo

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Serban Puricel, Diego Arroyo, Noé Corpataux et al. · Journal of the American College of Cardiology · 2015 · 200 citations

Medicine, Biomedical Engineering, Cardiology +14

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

Xavier Rosselló, Sergio Raposeiras‐Roubín, Roberto Latini et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2021 · 65 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial

Diego Arroyo, Gregoire Gendre, Sara Schukraft et al. · International Journal of Cardiology · 2017 · 35 citations

Medicine, Cardiology, Surgery +17

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Diego Arroyo, Mario Togni, Serban Puricel et al. · Trials · 2014 · 21 citations · Full text

Medicine, Cardiology, Drug Delivery +15

A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts

Laura Bravo, Joana F F Simoes, Victor Roth Cardoso et al. · The Lancet Digital Health · 2024 · 20 citations · Full text

Medicine, Perioperative Medicine, Surgery +17